Advertisement

Cardiac differentiation at an initial low density of human-induced pluripotent stem cells

  • Minh Nguyen Tuyet Le
  • Mika Takahi
  • Kenshiro Maruyama
  • Akira Kurisaki
  • Kiyoshi OhnumaEmail author
Article

Abstract

A high density of human-induced pluripotent stem cells (hiPSCs) improves the efficiency of cardiac differentiation, suggesting the existence of indispensable cell-cell interaction signals. The complexity of interactions among cells at high density hinders the understanding of the roles of cell signals. In this study, we determined the minimum cell density that can initiate differentiation to facilitate cell-cell interaction studies. First, we co-induced cardiac differentiation in the presence of the glycogen synthase kinase-3β inhibitor CHIR99021 and activin A at various cell densities. At an initial low density, cells died within a few days in RPMI-based medium. We then investigated the culture conditions required to maintain cell viability. We used a basal medium excluding important components for the maintenance of hiPSC pluripotency, including activin A, basic fibroblast growth factor, and insulin. Supplementation of the basal medium with Rho-associated protein kinase inhibitor and insulin improved cell viability. Interestingly, addition of basic fibroblast growth factor enabled the expression of cardiac markers at the mRNA level but not the protein level. After further modification of the culture conditions, 10% of the cells expressed the cardiac troponin T protein, which is associated with cell contraction. The novel protocol for cardiac differentiation at an initial low cell density can also be used to evaluate high cell density conditions. The findings will facilitate the identification of cell signals required for cardiomyocyte formation.

Keywords

Human-induced pluripotent stem cells Cardiac differentiation Low cell density Cell-cell interaction 

Notes

Acknowledgments

This research was supported by AMED under Grant Number JP17bk0104011h0005 (to A.K. and K.O.) and Japanese government scholarship for foreign students who study in higher education institutions (to M.L.). The funding bodies had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.

Author contributions

M.L. and K.O. designed the project. A.K. established and provided the cell line for the experiments. M.L. performed all experiments. T.M. and K.M. assisted with the experiments. M.L. and K.O. wrote the manuscript, and all authors reviewed the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

Supplementary material

11626_2018_276_MOESM1_ESM.docx (514 kb)
ESM 1 (DOCX 513 kb)
Video S1

Application of F7-based media from day 1 to day 3 allowed cardiac expression at the protein level associated with contractile cardiomyocytes. (MP4 3436 kb)

11626_2018_276_MOESM3_ESM.mp4 (7.5 mb)
Video S2 Transient calcium concentration in cardiac differentiation at a low cell density on day 14 was recorded. (MP4 7685 kb)

References

  1. Brewer G, Torricelli J, Evege KE, Price JP (1994) Neurobasal medium/B27 supplement: a new serum-free medium combination for focus of neurons. Focus 16:6–9Google Scholar
  2. Burgess WH, Maciag T (1989) The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58:575–606CrossRefPubMedGoogle Scholar
  3. Burridge PW, Matsa E, Shukla P, Lin ZC, Churko JM, Ebert AD, Lan F, Diecke S, Huber B, Mordwinkin NM, Plews JR, Abilez OJ, Cui B, Gold JD, Wu JC (2014) Chemically defined generation of human cardiomyocytes. Nat Methods 11:855–860CrossRefPubMedPubMedCentralGoogle Scholar
  4. Cellular Dynamics International (2014) Modeling cardiac proliferation: bFGF induction with high contents analysis. Available via https://cellulardynamicscom/cdi_icellcpc_proliferation_ap-cpcpro141201/ Cited 08 Mar 2018
  5. Conlon FL, Lyons KM, Takaesu N, Barth KS, Kispert A, Herrmann B, Robertson EJ (1994) A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse. Development 120:1919–1928PubMedGoogle Scholar
  6. Dasgupta A, Wahed A (2014) Clinical chemistry, immunology and laboratory quality control, chapter 8 cardiac markers. Elsevier, AmsterdamGoogle Scholar
  7. Estarás C, Hsu H, Huang L, Jones K (2017) YAP repression of the WNT3 gene controls hESC differentiation along the cardiac mesoderm lineage. Genes Dev 31:2250–2263CrossRefPubMedPubMedCentralGoogle Scholar
  8. Freund C, Ward-van Oostwaard D, Monshouwer-Kloots J, van den Brink S, van Rooijen M, Xu X, Zweigerdt R, Mummery C, Passier R (2008) Insulin redirects differentiation from cardiogenic mesoderm and endoderm to neuroectoderm in differentiating human embryonic stem cells. Stem Cells 26:724–733CrossRefPubMedGoogle Scholar
  9. Furue MK, Na J, Jackson JP, Okamoto T, Jones M, Baker D, Hata RI, Moore HD, Sato JD, Andrews PW (2008) Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium. Proc Natl Acad Sci U S A 105:13409–13414CrossRefPubMedPubMedCentralGoogle Scholar
  10. Golob JL, Paige SL, Muskheli V, Pabon L, Murry CE (2008) Chromatin remodeling during mouse and human embryonic stem cell differentiation. Dev Dyn 237:1389–1398CrossRefPubMedPubMedCentralGoogle Scholar
  11. Hartman ME, Dai DF, Laflamme MA (2016) Human pluripotent stem cells: prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Adv Drug Deliv Rev 96:3–17CrossRefPubMedGoogle Scholar
  12. Hartung S, Schwanke K, Haase A, David R, Franz WM, Martin U, Zweigerdt R (2013) Directing cardiomyogenic differentiation of human pluripotent stem cells by plasmid-based transient overexpression of cardiac transcription factors. Stem Cells Dev 22:1112–1125CrossRefPubMedGoogle Scholar
  13. Hayashi Y, Chan T, Warashina M, Fukuda M, Ariizumi T, Okabayashi K, Takayama N, Otsu M, Eto K, Furue MK, Michiue T, Ohnuma K, Nakauchi H, Asashima M (2010) Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions. PLoS One 5:e14099CrossRefPubMedPubMedCentralGoogle Scholar
  14. Inoue S, Hori Y, Hirano Y, Inamoto T, Tabata Y (2005) Effect of culture substrate and fibroblast growth factor addition on the proliferation and differentiation of human adipo-stromal cells. J Biomater Sci Polym Ed 16:57–77CrossRefPubMedGoogle Scholar
  15. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J, Gepstein L (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108:407–414CrossRefPubMedPubMedCentralGoogle Scholar
  16. Kempf H, Olmer R, Haase A, Franke A, Bolesani E, Schwanke K, Robles-Diaz D, Coffee M, Gohring G, Drager G, Potz O, Joos T, Martinez-Hackert E, Haverich A, Buettner FF, Martin U, Zweigerdt R (2016) Bulk cell density and Wnt/TGFbeta signalling regulate mesendodermal patterning of human pluripotent stem cells. Nat Commun 7:13602CrossRefPubMedPubMedCentralGoogle Scholar
  17. Kim MS, Horst A, Blinka S, Stamm K, Mahnke D, Schuman J, Gundry R, Tomita-Mitchell A, Lough J (2015) Activin-A and Bmp4 levels modulate cell type specification during CHIR-induced cardiomyogenesis. PLoS One 10:e0118670CrossRefPubMedPubMedCentralGoogle Scholar
  18. Kinehara M, Kawamura S, Tateyama D, Suga M, Matsumura H, Mimura S, Hirayama N, Hirata M, Yamada KU, Kohara A, Yanagihara K, Furue MK (2013) Protein kinase C regulates human pluripotent stem cell self-renewal. PLoS One 8:e54122CrossRefPubMedPubMedCentralGoogle Scholar
  19. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25:1015–1024CrossRefPubMedGoogle Scholar
  20. Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM, Raval KK, Zhang J, Kamp TJ, aP SP (2012) Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A 109:E1848–E1857CrossRefPubMedPubMedCentralGoogle Scholar
  21. Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, Hsiao C, Kamp TJ, Palecek SP (2013a) Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat Protoc 8:162–175CrossRefPubMedGoogle Scholar
  22. Lian X, Zhang J, Zhu K, Kamp TJ, Palecek SP (2013b) Insulin inhibits cardiac mesoderm, not mesendoderm, formation during cardiac differentiation of human pluripotent stem cells and modulation of canonical Wnt signaling can rescue this inhibition. Stem Cells 31:447–457CrossRefPubMedPubMedCentralGoogle Scholar
  23. Moore G, Gerner R, Franklin H (1967) Culture of normal human leukocytes. JAMA 199:519–524CrossRefPubMedGoogle Scholar
  24. Ninomiya H, Mizuno K, Terada R, Miura T, Ohnuma K, Takahashi S, Asashima M, Michiue T (2015) Improved efficiency of definitive endoderm induction from human induced pluripotent stem cells in feeder and serum-free culture system. In Vitro Cell Dev Biol Anim 51:1–8CrossRefPubMedGoogle Scholar
  25. Nishimura K, Sano M, Ohtaka M, Furuta B, Umemura Y, Nakajima Y, Ikehara Y, Kobayashi T, Segawa H, Takayasu S, Sato H, Motomura K, Uchida E, Kanayasu-Toyoda T, Asashima M, Nakauchi H, Yamaguchi T, Nakanishi M (2011) Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. J Biol Chem 286:4760–4771CrossRefPubMedGoogle Scholar
  26. Paige SL, Osugi T, Afanasiev OK, Pabon L, Reinecke H, Murry CE (2010) Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One 5:e11134CrossRefPubMedPubMedCentralGoogle Scholar
  27. Qiu XX, Liu Y, Zhang YF, Guan YN, Jia QQ, Wang C, Liang H, Li YQ, Yang HT, Qin YW, Huang S, Zhao XX, Jing Q (2017) Rapamycin and CHIR99021 coordinate robust cardiomyocyte differentiation from human pluripotent stem cells via reducing p53-dependent apoptosis. J Am Heart Assoc 6:e005295CrossRefPubMedPubMedCentralGoogle Scholar
  28. Straus DS (1981) Effects of insulin on cellular growth and proliferation. Life Sci 29:2131–2139CrossRefPubMedGoogle Scholar
  29. Sugi Y, Lough J (1995) Activin A and FGF2 mimic the inductive effects of anterior endoderm on terminal cardiac myogenesis in vitro. Dev Biol 168:567–574CrossRefPubMedGoogle Scholar
  30. Sumi T, Tsuneyoshi N, Nakatsuji N, Suemori H (2008) Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling. Development 135:2969–2979CrossRefPubMedGoogle Scholar
  31. Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, Wataya T, Takahashi JB, Nishikawa S, Nishikawa S, Muguruma K, Sasai Y (2007) A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25:681–686CrossRefPubMedGoogle Scholar
  32. Winnier G, Blessing M, Labosky PA, Hogan BLM (1995) Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9:2105–2116CrossRefPubMedGoogle Scholar
  33. Xu XQ, Graichen R, Soo SY, Balakrishnan T, Rahmat SN, Sie hS, Tham SC, Freund C, Moore J, Mummery C, Colman A, Zweigerdt R, Davidson BP (2008) Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation 76:958–970CrossRefPubMedGoogle Scholar
  34. Zhang J, Klos M, Wilson GF, Herman AM, Lian X, Raval KK, Barron MR, Hou L, Soerens AG, Yu J, Palecek SP, Lyons GE, Thomson JA, Herron TJ, Jalife J, Kamp TJ (2012) Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res 111:1125–1136CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Society for In Vitro Biology 2018

Authors and Affiliations

  1. 1.Department of BioengineeringNagaoka University of TechnologyNagaokaJapan
  2. 2.Department of Science of Technology InnovationNagaoka University of TechnologyNagaokaJapan
  3. 3.Graduate School of Biological SciencesNara Institute of Science and TechnologyIkomaJapan
  4. 4.Biotechnology Research Institute for Drug DiscoveryNational Institute of Advanced Industrial Science and TechnologyIbarakiJapan

Personalised recommendations